Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology.
The transaction valued the Tel Aviv-based company at over $1 billion with the Asia Pacific region being its largest market.
“Lumenis has built a market-leading position by creating some of the most innovative technologies in the industry,” said Yan Jiao, managing director at Baring Private Equity Asia, commented: "It is a clear leader worldwide, especially in Asia  . . .
Not a subscriber yet? Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators